Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative)

v3.6.0.2
STOCKHOLDERS' DEFICIT (Details Narrative)
1 Months Ended 3 Months Ended
Dec. 29, 2016
USD ($)
shares
Dec. 21, 2016
USD ($)
shares
Dec. 06, 2016
shares
Nov. 30, 2016
USD ($)
Number
shares
Oct. 02, 2016
$ / shares
shares
Sep. 29, 2016
USD ($)
$ / shares
shares
Sep. 22, 2016
USD ($)
$ / shares
shares
Sep. 21, 2016
USD ($)
shares
Sep. 20, 2016
shares
Sep. 19, 2016
USD ($)
$ / shares
Aug. 24, 2016
Apr. 05, 2016
USD ($)
$ / shares
shares
Jan. 15, 2016
USD ($)
shares
Sep. 06, 2015
USD ($)
Dec. 29, 2016
USD ($)
shares
Nov. 30, 2016
USD ($)
Number
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
Sep. 30, 2016
$ / shares
shares
Sep. 16, 2016
Investor
Mar. 26, 2013
shares
Dec. 10, 2012
shares
Mar. 22, 2012
shares
Aug. 03, 2006
$ / shares
shares
Common stock authorized previously                                 180,000,000              
Common stock authorized                                 500,000,000   500,000,000          
Description of reverse stock-split                

1-for-200

 

1-for-200

         

Approved a 1-for-200 reverse stock-split which was effected on September 21, 2016.

             
Common and preferred stock authorized                                 515,000,000              
Blank-check preferred stock authorized                                 15,000,000              
Blank-check preferred stock par value (in dollars per share) | $ / shares                                 $ 0.001              
Common stock issued                 200               2,261,061   1,941,061          
Common stock outstanding                 200               2,261,061   1,941,061          
Amount of debt converted | $                                 $ 5,300,000              
Number of options outstanding                                 325,095   223,120          
Number of options exercised                                              
Common stock exercise price (in dollars per share) | $ / shares                                 $ 36.74   $ 50.98          
Number of stock options granted                                 102,000              
Total unrecognized stock-based compensation | $                                 $ 474,300              
Intrinsic value of award granted booked as prepaid expenses | $                                 560,000              
Amortization of prepaid expenses | $                                 $ 280,000              
2006 Stock Incentive Plan [Member]                                                
Number of shares reserved for future issuance                                               3,339
Number of options outstanding                                 2,199              
Number of options exercised                                 355              
Number of shares expired                                 754              
2012 Omnibus Incentive Compensation Plan [Member]                                                
Aggregate intrinsic value of awarded shares | $           $ 840,000 $ 720,000                                  
Number of options outstanding                                 322,896              
Common stock exercise price (in dollars per share) | $ / shares             $ 6.00                                  
Number of options authorized                       200,000                 75,000 27,500 1,667  
Description of plan terms            

(i) increase the total number of shares of Common Stock available for grant under the 2012 Plan from 200,000 shares to an aggregate of 500,000 shares, (ii) add an "evergreen" provision which, on January 1st of each year through 2022, automatically increases the number of shares subject to the 2012 Plan by the lesser of: (a) a number equal to 10% of the shares of Common Stock authorized under the 2012 Plan as of the preceding December 31st, or (b) an amount, or no amount, as determined by the Board, but in no event may the number of shares of Common Stock authorized under the 2012 Plan exceed 885,781 and (iii) increase the annual individual award limits under the 2012 Plan to 100,000 shares of Common Stock, subject to adjustment in accordance with the 2012 Plan.

                                 
Stock Compensation Plan [Member]                                                
Weighted exercise price of awarded shares (in dollars per share) | $ / shares                       $ 5.10                        
Aggregate intrinsic value of awarded shares | $                       $ 70,100                        
Restricted Stock [Member] | 2006 Stock Incentive Plan [Member]                                                
Number of equity instruments other than options outstanding                                 31              
Restricted Stock [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of shares reserved for future issuance                                 33,354              
Number of equity instruments other than options outstanding                                 143,750              
Mr. Robin L. Smith [Member]                                                
Amount of debt converted | $ [1]                                 $ 100,000              
Mr. Robin L. Smith [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             40,000                                  
Description of vesting rights            

a) 20% vested on the date of grant, (b) 20% vested upon receiving CMS approval to bill Medicare, (c) 20% vested upon signing a multi-practitioner group to use our PEER technology (d) 20% will vest upon signing a healthcare system to use our PEER technology, and (e) 20% will vest upon up-listing to an exchange in 1 year;

                                 
Mr. Robin L. Smith [Member] | Private Placement [Member]                                                
Number of common stock issued       16,000                       16,000                
Proceeds from issuance of private placement | $       $ 100,000                       $ 100,000                
Mr. Robin L. Smith [Member] | Stock Compensation Plan [Member]                                                
Number of awarded shares                       5,000                        
Geoffrey E. Harris [Member]                                                
Amount of debt converted | $ [2]                                 10,000              
Geoffrey E. Harris [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             20,000                                  
Geoffrey E. Harris [Member] | Stock Compensation Plan [Member]                                                
Number of awarded shares                       2,500                        
Other Directors [Member] | Stock Compensation Plan [Member]                                                
Number of awarded shares                       1,250                        
Mr. George Carpenter [Member]                                                
Number of awarded shares                       5,000                        
Amount of debt converted | $ [3]                                 100,000              
Mr. George Carpenter [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             32,000                                  
Description of vesting rights            

(a) 25% vested on the date of grant, (b) 25% vested on the date that we received CNS approval to bill Medicare, (c) 25% vested upon signing a multi-practitioner group to use our PEER technology, and (d) 25% will vest upon signing a healthcare system to use our PEER technology;

                                 
Mr. Paul Buck [Member]                                                
Number of awarded shares                       5,000                        
Mr. Paul Buck [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             32,000                                  
Description of vesting rights            

(a) 25% vested on the date of grant, (b) 25% vested on the date that we received CNS approval to bill Medicare, (c) 25% will vest upon signing a healthcare system to use our PEER technology and (d) 25% will vest upon up-listing to an exchange in 1 year;

                                 
Mr. George Carpenter & Mr. Paul Buck [Member]                                                
Weighted exercise price of awarded shares (in dollars per share) | $ / shares                       $ 5.10                        
Aggregate intrinsic value of awarded shares | $                       $ 51,000                        
Description of vesting rights                      

50% vested on the date of grant and the remaining 50% vest pro rata over twelve months starting on the date of grant.

                       
Intrinsic value of award granted booked as prepaid expenses | $                       $ 25,500         6,400              
Amortization of prepaid expenses | $                                 19,100              
Six Accredited Investors [Member] | Private Placement [Member]                                                
Number of common stock issued                               160,000                
Proceeds from issuance of private placement | $                               $ 1,000,000                
Number of accredited investors | Number       6                       6                
John Pappajohn [Member]                                                
Amount of debt converted | $ [4]                                 1,600,000              
Number of accredited investors | Investor                                       12        
John Pappajohn [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             20,000                                  
John Pappajohn [Member] | Private Placement [Member]                                                
Number of common stock issued 16,000                           48,000 32,000                
Proceeds from issuance of private placement | $ $ 100,000                           $ 300,000 $ 200,000                
Mr. Thomas Tierney (Tierney Family Trust) [Member]                                                
Amount of debt converted | $ [5]                                 640,000              
Mr. Thomas Tierney (Tierney Family Trust) [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Weighted exercise price of awarded shares (in dollars per share) | $ / shares           $ 6.00                                    
Number of awarded shares           20,000                                    
Aggregate intrinsic value of awarded shares | $           $ 120,000                                    
Mr. Thomas Tierney (Tierney Family Trust) [Member] | Private Placement [Member]                                                
Number of common stock issued       32,000                       32,000                
Proceeds from issuance of private placement | $       $ 200,000                       $ 200,000                
Four Accredited Investors [Member]                                                
Amount of debt converted | $                           $ 200,000                    
Four Accredited Investors [Member] | Private Placement [Member]                                                
Number of common stock issued   48,000                                            
Proceeds from issuance of private placement | $   $ 300,000                                            
Two Accredited Investors [Member] | Private Placement [Member]                                                
Number of common stock issued 32,000                                              
Proceeds from issuance of private placement | $ $ 200,000                                              
Staff Members [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares                       1,000                        
Common stock exercise price (in dollars per share) | $ / shares         $ 6.00             $ 5.10                        
Number of stock options granted         102,000             7,250                        
Description of vesting rights        

Options vest pro-rata over 12 months starting on the date of grant.

           

These shares vest pro-rata over 12 months starting on the date of grant.

                       
Mr. Andrew H. Sassine [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             20,000                                  
Mr. Zachary McAdoo [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             20,000                                  
Directors and Officers [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             144,000                                  
Common stock exercise price (in dollars per share) | $ / shares             $ 6.00                                  
Robert Follman (Follman Family Trust) [Member]                                                
Amount of debt converted | $ [6]                                 $ 550,000              
Robert Follman (Follman Family Trust) [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             20,000                                  
Mr. Michal Votruba [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Number of awarded shares             20,000                                  
Consulting Agreement [Member] | Dian Griesel International [Member]                                                
Aggregate intrinsic value of awarded shares | $                         $ 6,900                      
Monthly professional fees | $                         $ 5,000                      
Consulting Agreement [Member] | Dian Griesel International [Member]                                                
Number of shares issued upon services                         1,500                      
Second Omnibus Amendment [Member]                                                
Aggregate principal amount | $                   $ 6,000,000                            
Description of agreement                  

With a majority of over 80% of the holders of certain Convertible Notes issued between September 2014 and August 2016 in aggregate principal amount of $6,000,000 (the “Notes”), thereby amending: (i) the Notes, (ii) that certain Second Amended and Restated Note and Warrant Purchase Agreement dated as of December 23, 2015, as thereafter amended and (iii) the warrants ("Warrants") issued in connection with the Notes.

                           
Conversion price (in dollars per share) | $ / shares                   $ 5.00                            
Amount of debt converted | $               $ 6,000,000                                
Number of shares issued for debt settlement               1,263,406                                
Accrued interest | $                   $ 317,000                            
Common Stock Purchase Agreement [Member] | Aspire Capital Fund, LLC [Member]                                                
Number of common shares purchased     10,000,000                                          
Common Stock Purchase Agreement [Member] | Aspire Capital Fund, LLC [Member] | Commitment Shares [Member]                                                
Number of common shares purchased     80,000                                          
Minimum [Member]                                                
Description of reverse stock-split                                

1-for-10

1-for-10

           
Minimum [Member] | 2006 Stock Incentive Plan [Member]                                                
Common stock exercise price (in dollars per share) | $ / shares                                               $ 2,400
Minimum [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Common stock exercise price (in dollars per share) | $ / shares                                 $ 5.10              
Maximum [Member]                                                
Description of reverse stock-split                                

1-for-200

1-for-200

           
Maximum [Member] | 2006 Stock Incentive Plan [Member]                                                
Common stock exercise price (in dollars per share) | $ / shares                                               6,540
Maximum [Member] | 2012 Omnibus Incentive Compensation Plan [Member]                                                
Common stock exercise price (in dollars per share) | $ / shares                                 $ 600              
Weighted Average [Member] | 2006 Stock Incentive Plan [Member]                                                
Common stock exercise price (in dollars per share) | $ / shares                                               $ 4,090
[1] Dr. Robin Smith is the Chairman of the Board.
[2] Geoffrey Harris is a member of the Board and Chairman of the Audit Committee.
[3] George Carpenter is the CEO of the Company.
[4] John Pappajohn is a member of the Board. He purchased $1,600,000 of Notes of which $200,000 were assigned to four accredited investors on September 6, 2015. Approximately $10,400 of the total interest was attributable to such transferred Notes, resulting in an aggregate of 42,084 shares being issued upon the conversion of such transferred Notes.
[5] Thomas Tierney is a trustee of the Tierney Family Trust. Mr. Tierney originally joined the Board on February 25, 2013 and served as Chairman of the Board from March 26, 2013 through his resignation on May 22, 2015. On September 29, 2016 Mr. Tierney rejoined the Board. The Tierney Family Trust is a greater than 5% shareholder of the Company.
[6] Robert Follman is a trustee of the Follman Family Trust and is a member of the Board.